October 17, 2023

October 17th, 2023

Advancing American Freedom issued the following statement on Jack Lew’s nomination to be the U.S. Ambassador to Israel.

“In Israel’s moment of crisis, the United States needs a nominee with a track record of standing with Israel and supporting our ally,” said AAF Executive Director Paul Teller. “Instead, Jack Lew has a history of helping Iran evade sanctions and for defending the Obama administration’s decision not to veto a 2016 UN Security council resolution condemning Israeli settlements. The United States must be a united front against Hamas and Iran and send a clear message that there will be no softness or slack when dealing with these hostile powers.”

October 17th, 2023

Advancing American Freedom issued the following statement in response to the United States easing sanctions on Venezuelan oil.

“The Biden administration would rather beg for from any foreign nation or regime than allow for increased US production,” said AAF Executive Director Paul Teller. “President Biden drained the Strategic Petroleum Reserve to avoid bad publicity, and now has decided to ease sanctions on another regime that does not share the values of our nation. We must demonstrate American strength and leadership on the world stage by getting America back to being energy independent and unleash the full strength of American natural resources.”

Background:

In 2022, Advancing American Freedom committed $10 million to fighting for American energy and opposing Biden’s radical climate agenda. The main focus of that campaign was President Biden’s reliance on foreign adversaries for U.S. energy, and we are disappointed to see the President choose foreign energy over domestic production again today.

Read more on AAF’s Unleash American Energy campaign here:

AAF Energy Campaign

Future of Freedom: Energy

AAF Opposition to Electric Vehicle Transition

October 17th, 2023

The NIH was founded to support innovative medical research that saves lives. Tragically, Bernie Sanders has hijacked the nomination process to push the Biden administration to double down even harder on its innovation-killing price controls and harsh penalties on medical research companies. Monica Bertagnolli’s nomination is a Trojan horse for the progressive movement to further its anti-competitive and anti-innovation policy agenda that harms consumers’ access to quality healthcare and undermines critical research and development. The Senate HELP Committee should not advance this nomination and must take further steps to reverse the damaging impacts of Biden’s drug price control schemes.

AAF has written more about the danger of these policies being promoted by President Biden, Senator Sanders, and progressive Democrats here:

Price Controls Will Create Medical Shortages

Opposing Price Controls in the ‘Inflation Reduction Act’